HOME >> BIOLOGY >> NEWS
A closer look yields new clues to why bacteria stick to things

A bacterium's ability to change its hairstyle may help in the effort to clean contaminated groundwater for drinking, according to Penn State researchers.

People are continually moving into places that are hot, sunny and arid where drinking water is in short supply, says R. Kramer Campen, Penn State graduate student in geosciences. "The imperative to find ways to clean groundwater is paramount," he told attendees today (March 25) at the 225th American Chemical Society national meeting in New Orleans.

In the ocean, bacteria can be released into the water to clean up oil spills, carried to the target by the same currents that transport the oil. Groundwater poses a more difficult problem as these single-cell organisms tend to adhere to certain minerals in the soil preventing them from following the pollutant's trail. Bacterial adhesion is also responsible for many medical problems such as tooth decay and artificial limb and organ rejection. "There is a growing awareness that you need a molecular level understanding," says Campen. "At that level, the processes that cause a bacterium to adhere to a mineral in soil or to a tooth have to be the same."

For many years, scientists have noted that bacteria stick to iron particles in soil, but not to sand grains. Until recently, this has been explained by invoking the same forces that hold a balloon to the ceiling after you rub it on your sweater. Researchers thought that the tiny, negative electrical charges on sand grains repelled the negatively charged bacteria, while the positively charged iron attracted them.

However, Campen and his adviser, James Kubicki, assistant professor of geosciences, think it is all about the hair. Bacteria are covered with atomic-scale chains of complex sugar molecules with "one end fastened into the cell membrane and the rest extending outward," explains Campen. "The hair analogy is a good one."

The hairs, actually polymers, present a problem for the charge-based e
'"/>

Contact: A'ndrea Elyse Messer
aem1@psu.edu
814-865-9581
Penn State
25-Mar-2003


Page: 1 2

Related biology news :

1. New diagnostic tool brings effective treatment closer to patients
2. Researchers one step closer to Holy Grail of neurobiology
3. Getting closer
4. Neural stem cells take a step closer to the clinic
5. Technique brings immune-based therapies closer to reality
6. Dartmouth engineers closer to mass-producing therapeutic proteins
7. Crash in male saiga antelope numbers drives species closer to extinction
8. Researchers closer to defining function of two proteins involved in neurotransmitter release
9. A closer look at the genomes black holes
10. New mighty mice research brings muscle growth closer to reality
11. Hormone the trigger for fat metabolism; scientists closer to tests in humans

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: closer look yields new clues why bacteria stick things

(Date:5/19/2015)... May 18, 2015 Fingerprint Cards (FPC) ... FPC1025, FPC1145, FPC1155 and FPC1035 from one if its module ... and including Q3 2015 and the sensors will be used ... order values for 2015 hereby amount to 740 MSEK to ... of 140 MSEK and a number of smaller orders not ...
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
(Date:5/14/2015)... and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has announced ... Smart Mobile Devices " report to their offering. ... watershed year for fingerprint sensors in smartphones and tablets, ... fingerprint sensors a raison d,etre in the mobile milieu ... must-have feature in flagship smartphones. The key ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
(Date:5/21/2015)... , May 21, 2015  The EveryLife ... Hatch (R-UT) and Amy Klobuchar ... Now Accelerating Cures & Treatments, or OPEN ACT. ... disease patient advocacy organizations, this bipartisan legislation promises ... affordable medicines to rare disease patients by incentivizing ...
(Date:5/21/2015)... May 21, 2015  CytRx Corporation (NASDAQ: ... specializing in oncology, today announced positive updated results ... aldoxorubicin for the treatment of unresectable glioblastoma multiforme ... open-label, multisite trial is designed to investigate the ... whose tumors have progressed following prior treatment with ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Veolia’s ... an exclusive North American distribution agreement with VWR ... system. , With more than 160 years of ... and services for laboratory and production facilities, has ... excellence and differentiated services to enable science. ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 This year ... especially for lawns. US Patented Pearl’s Premium Ultra ... lawns around the country that are coming out of ... addresses a number of major global concerns related to ... “non-grass” grass – the alternative to the standard, water-wasting, ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2
Cached News: